东兴证券晨报-20260317

Core Insights - The report highlights the implementation of a more proactive fiscal policy in China, emphasizing the importance of expanding domestic demand and optimizing economic structure for 2026 [2] - The energy sector shows a positive trend with a 6.1% year-on-year increase in total electricity consumption in the first two months of 2026, indicating robust industrial activity [2] - The report identifies key companies in various sectors, including banking, technology, and food, as potential investment opportunities [4] Company-Specific Summaries Andy Su (安迪苏) - In 2025, Andy Su achieved a revenue of 17.23 billion yuan, reflecting a year-on-year growth of 10.92%, while net profit decreased by 4.13% to 1.155 billion yuan [8] - The functional products segment saw a revenue increase of 11.12% to 12.914 billion yuan, driven by strong sales of liquid methionine [9] - The company is expanding its methionine production capacity, with significant projects nearing completion, which will help maintain its leading position in the global market [10] - Profit forecasts for 2026-2028 are adjusted, with expected net profits of 1.454 billion, 1.682 billion, and 1.864 billion yuan, corresponding to P/E ratios of 30, 26, and 24 times [11] Shandong Pharmaceutical Glass (山东药玻) - In 2025, Shandong Pharmaceutical Glass reported a revenue of 4.474 billion yuan, down 8.78% year-on-year, with net profit declining by 26.87% to 690 million yuan [13] - The decline in revenue is attributed to weak industry demand, influenced by healthcare payment reforms and centralized procurement [15] - The company improved its gross margin to 33.31%, aided by cost reductions in raw materials and enhanced automation [16] - Future profit projections for 2026-2028 are set at 762 million, 859 million, and 1.011 billion yuan, with corresponding P/E ratios of 17, 15, and 13 times [19]